A hidden route for ovarian cancer spread?
NCT ID NCT06237582
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This study investigates whether lymph nodes in the lower abdomen, called the inferior epigastric lymph node basin, might be an early stop for ovarian cancer spreading from the peritoneum. Researchers will biopsy these nodes in 20 patients undergoing surgery for ovarian peritoneal metastases to see how often they contain cancer cells. The goal is to understand if this pathway could serve as a marker for how the disease progresses and its risk of spreading further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- epigastric lymph node biopsy
- What this could lead to
- If this pathway is confirmed, it could lead to better prediction of how ovarian cancer spreads and possibly new ways to prevent systemic metastasis.
- What could go wrong
- This is a small, early study with only 20 participants, so findings may not apply broadly. The procedure is invasive and carries surgical risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMATOSIS, PERITONEAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Jules Bordet
Brussels, 1070, Belgium